ACS nano

Rapid Test Using Fluorescent DNA Amplification and CRISPR to Detect Bacteria in Lower Lung Infections

Updated

Abstract

FLEMD-CRISPR enables simultaneous quantification of nucleic acid targets from eight bacterial pathogens associated with lower respiratory tract infections.

  • The assay utilizes fluorescence encoding and deterministic droplet pairing to improve multiplexing capacity.
  • Strong linear correlation (R2 = 0.9987-0.9998) and consistent detection efficiency (slopes = 0.9849-1.0198) were observed in comparison to single-plex digital PCR.
  • The complete workflow can be finished within 2 hours, from sample preparation to readout.
  • Clinical validation with 30 bronchoalveolar lavage fluid samples demonstrated 100% positive percent agreement and 99.1% negative percent agreement with standard culture methods.
  • FLEMD-CRISPR allows for flexible panel reconfiguration through modifications to the droplet encoding library.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free